{"schema_version":"1","generated_at":"2026-10-29T08:37:51.742Z","data_as_of":null,"url":"https://www.findmykol.com/kol/grerk-sutamtewagul","json_url":"https://www.findmykol.com/kol/grerk-sutamtewagul/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"grerk-sutamtewagul","name":"Grerk Sutamtewagul","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Iowa","institution_url":"https://www.findmykol.com/institution/university-of-iowa","city":"Iowa City","state":"IA","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1003103383","orcid":"0000-0002-1311-6227","openalex":"A5056737997"},"summary":"Grerk Sutamtewagul is an Oncology physician affiliated with University of Iowa. OpenAlex indexes 76 publications with 508 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":76,"cited_by_count":508,"h_index":12,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2023,"amount_usd":19.81,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003103383"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1003103383","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":67.8,"classes_total":6,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":52,"drugs":[{"name":"Calquence","share_pct":24.3},{"name":"Jakafi","share_pct":21.6},{"name":"Imatinib Mesylate","share_pct":16.9},{"name":"Brukinsa","share_pct":8.6},{"name":"Imbruvica","share_pct":8.1},{"name":"Sprycel","share_pct":6.3},{"name":"Jaypirca","share_pct":5.9},{"name":"Tasigna","share_pct":5.9},{"name":"Ayvakit","share_pct":2.5}],"max_beneficiaries":null},{"class":"Calcineurin inhibitor","setting":"prescribed","share_pct":4.4,"drugs":[{"name":"Cyclosporine","share_pct":36.8},{"name":"Gengraf","share_pct":31.6},{"name":"Cyclosporine Modified","share_pct":31.6}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":8.9,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":6.8,"drugs":[{"name":"Xarelto","share_pct":50},{"name":"Eliquis","share_pct":50}],"max_beneficiaries":null},{"class":"Erythropoiesis-stimulating Agent","setting":"prescribed","share_pct":2.1,"drugs":[{"name":"Procrit","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":6.9,"classes_total":2,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":4.2,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":19},{"class":"Corticosteroid","setting":"prescribed","share_pct":2.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":14}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Anthracycline Chemotherapy does not Increase Arterial Stiffness or Carotid Intima-Media Thickness in Young Adult Survivors of Hematological Malignancies","year":2026,"journal":"Journal of Applied Physiology","source_url":"https://doi.org/10.1152/japplphysiol.00271.2026","status":"verified"},{"title":"Leveraging Natural Language Processing for Symptom Identification in Acute Myeloid Leukemia Using Clinical Notes from Electronic Health Records","year":2026,"journal":"Cancer Nursing","source_url":"https://doi.org/10.1097/ncc.0000000000001570","status":"verified"},{"title":"Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial","year":2025,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-025-58179-6","status":"verified"},{"title":"Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies","year":2025,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-025-02515-8","status":"verified"},{"title":"Ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-m acute myeloid leukemia: Phase 1b results from KOMET-007","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-766","status":"verified"}],"source":"works"},"contact":{"address_1":"200 HAWKINS DR","address_2":"DEPT OF INTERNAL MEDICINE","city":"Iowa City","state":"IA","zip":"522421009","phone":"319-356-1616","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1003103383","source":"identity"},"similar":[{"name":"Lawrence Hunsicker","slug":"lawrence-hunsicker","institution":"University of Iowa","specialty":"Nephrology","url":"https://www.findmykol.com/kol/lawrence-hunsicker","json_url":"https://www.findmykol.com/kol/lawrence-hunsicker/profile.json"},{"name":"Brian Olshansky","slug":"brian-olshansky","institution":"University of Iowa","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/brian-olshansky","json_url":"https://www.findmykol.com/kol/brian-olshansky/profile.json"},{"name":"Robert Weiss","slug":"robert-weiss","institution":"University of Iowa","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/robert-weiss","json_url":"https://www.findmykol.com/kol/robert-weiss/profile.json"},{"name":"Carla Nester","slug":"carla-nester","institution":"University of Iowa","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/carla-nester","json_url":"https://www.findmykol.com/kol/carla-nester/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-01-29","provider_certified":"2020-01-29","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}